[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 174.129.114.211. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
January 21, 2004

Antibiotics and Coronary Heart Disease

Author Affiliations
 

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2004;291(3):302. doi:10.1001/jama.291.3.302-a

To The Editor: Dr O'Connor and colleagues1 reported that a 3-month course of azithromycin did not significantly reduce the clinical sequelae of coronary heart disease (CHD) among stable patients with previous myocardial infarction and evidence of Chlamydia pneumoniae exposure. Exposure to this pathogen is, in fact, highly prevalent in the population (more than 80% of people older than 65 years may have the antibody).2

First Page Preview View Large
First page PDF preview
First page PDF preview
×